Colorectal cancer laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(11 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Colon cancer}}
{{Colon cancer}}
To view the laboratory findings of familial adenomatous polyposis (FAP), click [[Familial adenomatous polyposis laboratory findings|'''here''']]<br>
To view the laboratory findings of hereditary nonpolyposis colorectal cancer (HNPCC), click [[Hereditary nonpolyposis colorectal cancer laboratory findings|'''here''']]<br><br>
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.


{{CMG}}; {{AE}} {{RT}}
==Overview==
The laboratory findings associated with colorectal carcinoma are the following: [[Complete blood count|CBC]], [[FOBT]], [[CEA|serum CEA]] and [[CA 19-9|CA 19-9 concentration]], [[Serum iron|serum iron concentrations]], [[Vitamin B12|serum vitamin B12]] and [[Folate|folate concentrations]], [[liver function tests]], and [[pulmonary function tests]].


==Overview==
== Colorectal Cancer Laboratory Findings==
Laboratory findings consistent with the diagnosis of colorectal cancer include:


==Laboratory Findings==
* Complete blood count and differential count - [[anemia]]
* [[Fecal occult blood test]]([[FOBT]]) - demonstrates occult bleeding from the intestines
* Serum [[carcino-embryogenic antigen]]([[CEA]]) levels - has a prognostic value.  Elevated levels have a poor outcome.
* Serum iron levels
* Serum vitamin B12 and folate levels


===Test for Metastasis===
*[[Complete blood count]] and differential count
* [[Liver function tests]] - abnormal
**[[anemia]]
* [[Lung function tests]]
**Individuals with [[microcytic anemia]] over 50 years of age are suspected of having colorectal cancer.<ref name="ZhuKaneshiro2010">{{cite journal|last1=Zhu|first1=Amy|last2=Kaneshiro|first2=Marc|last3=Kaunitz|first3=Jonathan D.|title=Evaluation and Treatment of Iron Deficiency Anemia: A Gastroenterological Perspective|journal=Digestive Diseases and Sciences|volume=55|issue=3|year=2010|pages=548–559|issn=0163-2116|doi=10.1007/s10620-009-1108-6}}</ref>
*[[Fecal occult blood test]]([[FOBT]])
**Demonstrates occult bleeding from the intestines
*Serum [[carcino-embryogenic antigen]] ([[CEA]]) and [[CA 19-9]] <ref name="pmid10528904">{{cite journal| author=Macdonald JS| title=Carcinoembryonic antigen screening: pros and cons. | journal=Semin Oncol | year= 1999 | volume= 26 | issue= 5 | pages= 556-60 | pmid=10528904 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10528904  }}</ref>
**Elevated concentrations associated with larger tumor masses and have a poorer prognosis
**Sensitivity of CEA in diagnosis of colorectal cancer is almost 50%<ref name="pmid25105762">{{cite journal| author=Liu Z, Zhang Y, Niu Y, Li K, Liu X, Chen H et al.| title=A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer. | journal=PLoS One | year= 2014 | volume= 9 | issue= 8 | pages= e103910 | pmid=25105762 | doi=10.1371/journal.pone.0103910 | pmc=4126674 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25105762  }}</ref>


==References==
==References==
Line 22: Line 26:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Oncology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Conditions diagnosed by stool test]]
[[Category:Conditions diagnosed by stool test]]
Line 29: Line 32:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Surgery]]

Latest revision as of 20:15, 28 January 2019

Colorectal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Colorectal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Metastasis Treatment

Primary Prevention

Secondary Prevention

Follow-up

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Colorectal cancer laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Colorectal cancer laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Colorectal cancer laboratory tests

CDC on Colorectal cancer laboratory tests

Colorectal cancer laboratory tests in the news

Blogs on Colorectal cancer laboratory tests

Directions to Hospitals Treating Colorectal cancer

Risk calculators and risk factors for Colorectal cancer laboratory tests

To view the laboratory findings of familial adenomatous polyposis (FAP), click here
To view the laboratory findings of hereditary nonpolyposis colorectal cancer (HNPCC), click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

Overview

The laboratory findings associated with colorectal carcinoma are the following: CBC, FOBT, serum CEA and CA 19-9 concentration, serum iron concentrations, serum vitamin B12 and folate concentrations, liver function tests, and pulmonary function tests.

Colorectal Cancer Laboratory Findings

Laboratory findings consistent with the diagnosis of colorectal cancer include:


References

  1. Zhu, Amy; Kaneshiro, Marc; Kaunitz, Jonathan D. (2010). "Evaluation and Treatment of Iron Deficiency Anemia: A Gastroenterological Perspective". Digestive Diseases and Sciences. 55 (3): 548–559. doi:10.1007/s10620-009-1108-6. ISSN 0163-2116.
  2. Macdonald JS (1999). "Carcinoembryonic antigen screening: pros and cons". Semin Oncol. 26 (5): 556–60. PMID 10528904.
  3. Liu Z, Zhang Y, Niu Y, Li K, Liu X, Chen H; et al. (2014). "A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer". PLoS One. 9 (8): e103910. doi:10.1371/journal.pone.0103910. PMC 4126674. PMID 25105762.


Template:WikiDoc Sources